D-400-2014 Class III Terminated

Recalled by Mutual Pharmaceutical Company, Inc. — Philadelphia, PA

Recall Details

Product Type
Drugs
Report Date
January 15, 2014
Initiation Date
February 27, 2013
Termination Date
April 1, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity

Product Description

Fenofibric Acid, immediate release tablet, 105 mg, a) 30 count bottle (NDC 53489-678-07), b) 90 count bottle (NDC 53489-678-90), Rx only, Mutual Pharmaceutical Co., Inc., Philadelphia, PA 19124 USA

Reason for Recall

Labeling: Incorrect instructions; an error in section 5.11 of the patient insert that results in incorrect medical advice. Specifically, the labeling should read "If a severely depressed HDL-C level is detected, fibrate therapy should be withdrawn, and the HDL-C level monitored until it has returned to baseline, and fibrate therapy should not be re-initiated." The labeling for the recalled lots

Distribution Pattern

Nationwide and Puerto Rico.

Code Information

lot 6581105 & 6581106 exp. 07/15, and lot 6623001 & 6623002 exp. 01/16